The FindingMS project is an interdisciplinary research project funded within the joint transnational call ERA PerMed (2018) with the aim to contribute to the personalized treatment in multiple sclerosis. The main objective of FindingMS is to carry out a thorough investigation of molecular events that could confer risk of disease activity, incorporating clinical data, lifestyle features and multiple - omics profiles, and to build a predictive algorithm of MS disease activity that will enable personalized treatment of MS.


The project will benefit from the collaboration of four partners with demonstrated broad expertise in the field of personalized medicine and systems biology: the IRCCS San Raffaele Hospital, the Centre Hospitalier Universitaire de Toulouse, the Institute of Biomedical Technologies at the Italian National Research Council and geneXplain. Overall, the involved partners put in place complementary skills, able to cover the different aspects of the project.


We believe that the present project is clinically relevant and could have a positive impact in MS patients management through the identification of clinical, molecular and environmental parameters associated with disease activity. We will build a predictive model of disease activity that could be easily transferred into the clinical practice, given that no major invasive procedures are required to obtain the biological samples that are necessary to perform the multi-omics profiling coupled with clinical, paraclinical and environmental information.
The FindingMS project is funded by the Fondazione Regionale per la Ricerca Biomedica (Italy), the Agence Nationale de la Recherche (France) and the Federal Ministry of Education and Research (Germany), within the ERA-Net Cofund Joint Transnational Calls ERA PerMed. The contents of this website are the sole responsibility of the FindingMS project and do not necessarily reflect the views of the European Union and funding agencies.